J. C. Stoof

发表

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

J. C. Stoof, J. Kebabian, 1981, Nature.

Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum

J. C. Stoof, J. Kebabian, 1982, Brain Research.

Drug-naive patients with Parkinson’s disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]β-CIT SPECT

J. C. Stoof, E. Wolters, J. Booij, 1997, Journal of Neurology.

An evaluation of the young dopamine-lesioned rat as an animal model for minimal brain dysfunction (MBD)

J. C. Stoof, R. Thieme, H. Dijkstra, 1980, Psychopharmacology.

beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson ' s disease

J. Booij, J. C. Stoof, J. Booij, 2003 .

Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease

J. Booij, J. C. Stoof, E. Wolters, 2005, European Journal of Nuclear Medicine.

D-2 dopamine-receptors regulate the release of [3H]dopamine in rat cortical regions showing dopamine immunoreactive fibers

J. C. Stoof, H. Steinbusch, J. Schipper, 1987, Neuroscience.

Studies on the nature of the releasable pool of dopamine in synaptosomes from rat corpus striatum: Depolarization-induced release of 3H-dopamine from superfused synaptosomes labelled under various conditions

J. C. Stoof, A. H. Mulder, C. D. Langen, 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

Presence of glutathione immunoreactivity in cultured neurones and astrocytes.

J. C. Stoof, O. Ottersen, B. Drukarch, 1996, Neuroreport.

Glutathione Is Involved in the Granular Storage of Dopamine in Rat PC12 Pheochromocytoma Cells: Implications for the Pathogenesis of Parkinson’s Disease

J. C. Stoof, B. Drukarch, E. Schepens, 1996, The Journal of Neuroscience.

[123I]β-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls

J. C. Stoof, E. Wolters, J. Booij, 1997, European Journal of Nuclear Medicine.

Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease.

J. C. Stoof, J. Leysen, B. Drukarch, 1988, Life sciences.

The Role of Glutathione in the Pathogenesis of Parkinson’s Disease

J. C. Stoof, B. Drukarch, 1997 .

Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices.

J. C. Stoof, A. Bast, B. Drukarch, 1995, Free radical biology & medicine.

Dopamine Receptors in the Neostriatum: Biochemical and Physiological Studies

J. C. Stoof, 1983 .

Repeated administration of a selective dopamine D2 receptor agonist to 6-OHDA — lesioned rats does not affect the survival and outgrowth of intrastriatal fetal mesencephalic grafts

J. C. Stoof, J. Ruijter, J. Bol, 2004, Experimental Brain Research.

Stimulation of D-2 dopamine receptors in rat mesocortical areas inhibits the release of [3H]dopamine.

J. C. Stoof, F. Dijcks, P. Verheijden, 1985, European journal of pharmacology.

Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development

J. C. Stoof, A. Bast, B. Drukarch, 1995, Neuroscience Letters.

12 - Unilateral MPTP-Lesioned Monkey as an Animal Model for Parkinson's Disease

J. C. Stoof, E. Wolters, C. Goosen, 1991 .

The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958.

J. C. Stoof, A. Cools, G. Andringa, 1999, Behavioural pharmacology.

The quinolinic acid hypothesis in Huntington's chorea

J. C. Stoof, R. Bruyn, R.P.M. Bruyn, 1990, Journal of the Neurological Sciences.

[ I] b -CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease

J. C. Stoof, J. Booij, A. Winogrodzka, 2003 .

Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species.

J. C. Stoof, F. L. van Muiswinkel, B. Drukarch, 1998, Free radical biology & medicine.

Dopamine D2 receptor stimulation differentially affects voltage‐activated calcium channels in rat pituitary melanotropic cells.

J. C. Stoof, K. Kits, J. A. Keja, 1992, The Journal of physiology.

Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase.

J. C. Stoof, A. H. Mulder, 1977, European journal of pharmacology.

Anethole dithiolethione prevents oxidative damage in glutathione-depleted astrocytes.

J. C. Stoof, B. Drukarch, C. Langeveld, 1997, European journal of pharmacology.

8-chloro-cyclic adenosine monophosphate, a novel cyclic AMP analog that inhibits human glioma cell growth in concentrations that do not induce differentiation

J. C. Stoof, J. Heimans, C. A. Jongenelen, 1992, Experimental Neurology.

Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro cyclic adenosine 3':5'-monophosphate.

J. C. Stoof, J. Heimans, C. A. Jongenelen, 1992, Cancer research.

Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review.

J. C. Stoof, J. Kebabian, R. Eskay, 1982, Neuroendocrinology.

Dopamine D1 receptor agonists display a different intrinsic activity in rat, monkey and human astrocytes.

J. C. Stoof, E. Wolters, B. Drukarch, 1994, European journal of pharmacology.

A simple superfusion technique for studying release of radiolabeled 5‐hydroxytryptamine from blood platelets without interference of reuptake

J. C. Stoof, A. H. Mulder, 1976, The Journal of pharmacy and pharmacology.

Vesamicol and some of its derivatives: questionable ligands for selectively labelling acetylcholine transporters in rat brain.

J. C. Stoof, J. Leysen, J. Herscheid, 1997, European journal of pharmacology.

Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN

J. C. Stoof, A. H. Mulder, A. Horn, 1980, Brain Research.

Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone

J. C. Stoof, J. Heimans, J. Wolbers, 1992, Journal of neuroscience research.

Indications for a hormonal function of dopamine in the central nervous system of the snail Lymnaea stagnalis

J. C. Stoof, T. D. Vlieger, T. Werkman, 1990, Neuroscience Letters.

Effect of penicillin on transmitter release from rat cortical tissue

J. C. Stoof, T. Boer, H. V. Duyn, 1980, Brain Research.

Subchronic treatment with the neuroleptic-like peptide desenkephalin- γ-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats

J. C. Stoof, F. S. Radhakishun, J. M. Ree, 1994, European Neuropsychopharmacology.

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

J B Habraken, J. C. Stoof, E. Wolters, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The antiproliferative effect of 8-chloro-adenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate, and disturbances in nucleic acid synthesis and cell cycle kinetics.

G. Peters, J. C. Stoof, J. Heimans, 1997, Biochemical pharmacology.

On the Role of Adenylate Cyclase in Presynaptic Modulation of Neurotransmitter Release Mediated by Monoamine and Opioid Receptors in the Brain

J. C. Stoof, A. Schoffelmeer, A. H. Mulder, 1990, Annals of the New York Academy of Sciences.

Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy.

H. Groenewegen, H. Groenewegen, J. C. Stoof, 1999, European journal of pharmacology.

The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis

J. C. Stoof, P. Boer, G. Damsma, 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

Localization of dopamine and its relation to the growth hormone producing cells in the central nervous system of the snail Lymnaea stagnalis

J. C. Stoof, P. Voorn, B. Westerink, 2004, Experimental Brain Research.

Chronic Dopamine D2 Receptor Activation Does Not Affect Survival and Differentiation of Cultured Dopaminergic Neurons: Morphological and Neurochemical Observations

J. C. Stoof, F. L. Muiswinkel, B. Drukarch, 1993, Journal of neurochemistry.

Application of functional in vitro model systems or the comparisons of the pharmacological characteristics of dopamine autoreceptors and postsynaptic D-2 receptors

J. C. Stoof, B. Drukarch, 1992, Neurochemistry International.

Lack of a dopamine autoreceptor selective profile of B-HT 920 in functional in vitro model systems of D2 receptors in rat striatum.

J. C. Stoof, B. Drukarch, P. de Boer, 1990, European journal of pharmacology.

Two dopamine receptors: biochemistry, physiology and pharmacology.

J. C. Stoof, J. Kebabian, 1984, Life sciences.

Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system

J. C. Stoof, A. H. Mulder, Wim B. Van Den Berg, 1975, Brain Research.

The neuroleptic-like peptide desenkephalin-γ-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitro

J. C. Stoof, F. S. Radhakishun, J. M. Ree, 1987, Brain Research.

9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.

J. C. Lodder, J. C. Stoof, K. Kits, 1987, European journal of pharmacology.

GABA modulates the release of dopamine and acetylcholine from rat caudate nucleus slices.

J. C. Stoof, A. H. Mulder, E. J. den Breejen, 1979, European journal of pharmacology.

Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: Indications for a common signal transduction pathway

J. C. Stoof, B. Drukarch, E. Schepens, 1990, Neuroscience.

Stimulation of D‐2 Dopamine Receptors Decreases the Evoked In Vitro Release of [3H] Acetylcholine from Rat Neostriatum: Role of K+ and Ca2+

J. C. Stoof, B. Drukarch, A. Schoffelmeer, 1989, Journal of neurochemistry.

The effects of convulsant and anticonvulsant drugs on the release of radiolabeled GABA, glutamate, noradrenaline, serotonin and acetylcholine from rat cortical slices

J. C. Stoof, T. Boer, H. Duijn, 1982, Brain Research.

THE FIELD TEST CONTROVERSY

J. C. Stoof, J. Koetsier, E. A. Caspary, 1979, The Lancet.

Sub-chronic administration of the dopamine D1 antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia

J. C. Stoof, A. Cools, G. Andringa, 1999, Psychopharmacology.

The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.

J. C. Stoof, A. Cools, J. Leysen, 1999, European journal of pharmacology.

Hormone receptors and glioma cell growth.

J. C. Stoof, J. Heimans, J. Wolbers, 1992, Journal of neurosurgery.

8-Chloro-Cyclic Adenosine Monophosphate is a Potent Inhibitor of Human Glioma Cell Proliferation In Vitro

J. C. Stoof, J. Heimans, C. Langeveld, 1991 .

D-2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5'-triphosphate.

J. C. Stoof, J. Kebabian, R. Eskay, 1982, Endocrinology.

The Role of Brain Dopamine

J. C. Stoof, J. Kornhuber, P. Riederer, 1989, Basic and Clinical Aspects of Neuroscience.

Biochemical profile of risperidone, a new antipsychotic.

J. C. Stoof, J. Leysen, P. Janssen, 1988, The Journal of pharmacology and experimental therapeutics.

EVALUATION OF THE RED BLOOD CELL CYTOPHEROMETRIC TEST FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS

J. C. Stoof, J. Koetsier, H. L. Langevoort, 1977, Acta neurologica Scandinavica.

Regulation of the activity of striatal cholinergic neurons by dopamine

H. Groenewegen, J. C. Stoof, P. Boer, 1992, Neuroscience.

Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin.

J. C. Stoof, P. Sminia, T. de Boer, 1982, European journal of pharmacology.

Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys

J. C. Stoof, E. Wolters, B. Drukarch, 1995, Psychopharmacology.

D-2 receptor stimulation inhibits cyclic AMP formation brought about by D-1 receptor stimulation in rat neostriatum but not nucleus accumbens.

J. C. Stoof, P. Verheijden, 1986, European journal of pharmacology.

Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

H. Berendse, J. C. Stoof, E. Wolters, 2001, Annals of neurology.

Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency

J. C. Stoof, B. Drukarch, B Drukarch, 1997, Brain Research.

Dihydropyridine block of ω-agatoxin IVA- and ω-conotoxin GVIA-sensitive Ca2+ channels in rat pituitary melanotropic cells

J. C. Stoof, H. Mansvelder, K. Kits, 1996 .

D-2 dopamine autoreceptor selective drugs: do they really exist?

J. C. Stoof, B. Drukarch, 1990, Life sciences.

The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.

J. C. Stoof, E. Wolters, R. Jeroen Vermeulen, 1993, European journal of pharmacology.

Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors

J. C. Stoof, A. Schoffelmeer, A. H. Mulder, 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Further pharmacological characterization of a D-2-like dopamine receptor on growth hormone producing cells in Lymnaea stagnalis.

J. C. Stoof, T. Werkman, J. Lodder, 1987, European journal of pharmacology.

Dopamine receptor stimulation induces a potassium dependent hyperpolarizing response in growth hormone producing neuroendocrine cells of the gastropod mollusc Lymnaea stagnalis.

J. C. Stoof, T. Werkman, J. Lodder, 1986, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

Opposing roles for D-1 and D-2 dopamine receptors in regulating the excitability of growth hormone-producing cells in the snail Lymnaea stagnalis.

J. C. Stoof, J. Lodder, T. A. de Vlieger, 1984, European journal of pharmacology.

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way.

J. C. Stoof, E. Wolters, J. Booij, 1992, European journal of pharmacology.

Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-d-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats

J. C. Stoof, P. Hoogland, J. Henselmans, 1991, Brain Research.

Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation

J. C. Stoof, J. Leysen, P. Verheijden, 1987, Brain Research.

Iodine-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Tropane SPECT in Healthy Controls and Early-Stage, Drug-Naive Parkinson's Disease

Jan Booij, E. A. Van Royen, J. C. Stoof, 1998 .

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

J. C. Stoof, E. Wolters, J. Booij, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Regional differences in the dopaminergic regulation of cyclic AMP formation within the rat nucleus accumbens: comparison with the striatal complex of the lizard Gekko gecko

J. C. Stoof, J. Henselmans, M. H. Heyna, 1993, Neuroscience Letters.

Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-d-aspartate receptor activation in rat nucleus accumbens and neostriatum

J. C. Stoof, J. Henselmans, 1991, Brain Research.

A comparative study of the dopamine-acetylcholine interaction in telencephalic structures of the rat and of a reptile, the lizardGekko gecko

J. C. Stoof, F. T. Russchen, P. Hoogland, 1987, Brain Research.

Circadian periodicity and stress responsiveness of the pituitary--adrenal system of rats after central administration of 6-hydroxydopamine.

J. C. Stoof, J. Kaplanski, C. Nyakas, 1974, The Journal of endocrinology.

Dopamine inhibits the release of immunoreactive β-endorphin from rat hypothalamus in vitro

J. C. Stoof, I. Vermes, F.J.H. Tilders, 1985, Brain Research.

Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro.

J. C. Stoof, P. Sminia, A. Schoffelmeer, 1985, European journal of pharmacology.

The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.

J. C. Stoof, F. Daus, J. F. Plantjé, 1984, European journal of pharmacology.

TWO DOPAMINE RECEPTORS, BIOCHEMISTRY, PHYSIOLOGY, PHARMACOLOGY

J. C. Stoof, J. Kebabian, 1984 .

Dopamine Receptors in the Central Nervous System

J. C. Stoof, F. Tilders, 1989 .

D2-dopamine receptors regulate the release of [3H]dopamine in rat basal hypothalamus and neurointermediate lobe of the pituitary gland

J. C. Stoof, J. Schipper, P. Verheijden, 1987, Brain Research.

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

J D Speelman, J. C. Stoof, E. Wolters, 1997, Journal of neurology, neurosurgery, and psychiatry.

Release and receptor stimulating properties of p-tyramine in rat brain.

J. C. Stoof, A. Liem, A. H. Mulder, 1976, Archives internationales de pharmacodynamie et de therapie.

Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activity.

J. C. Stoof, F. L. van Muiswinkel, B. Drukarch, 1995, Brain research. Developmental brain research.

Changes in the behavioral response to a novel environment following lesioning of the central dopaminergic system in rat pups

J. C. Stoof, H. Dijkstra, J. P. Hillegers, 1978, Psychopharmacology.

On the specificity and mechanism of action of m-tyrosine in antagonizing the central effects of reserpine in rats

J. C. Stoof, J. Schipper, A. H. Mulder, 1976, Neuropharmacology.

[123I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease

J. C. Stoof, E. Wolters, J. Booij, 2003, Journal of neurology, neurosurgery, and psychiatry.

Preclinical (premotor) Parkinson’s disease

H. Berendse, J. C. Stoof, E. Wolters, 2000, Journal of Neurology.

Trace amines, comparative and clinical neurobiology By A.A. Boulton, A. V. Juorio and R.G.H. Downer (eds.), Humana Press, Clifton, NJ, 1988, 476 pages, ISBN 0-89603-144-6, price not stated

J. C. Stoof, 1989, Journal of Neurological Sciences.

Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis

H. Berendse, J. C. Stoof, G. Tissingh, 2001, Movement disorders : official journal of the Movement Disorder Society.

dopaminergic degeneration in early stage Parkinson's disease

Jan Booij, J. C. Stoof, E. Wolters, 2006 .

E 123 I ] FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson ' s disease

J. C. Stoof, E. Wolters, J. Booij, 2003 .

Cyclic AMP production in the central nervous system of the snail Lymnaea stagnalis is stimulated by forskolin and 5-hydroxytryptamine but is not affected by dopamine

J. C. Stoof, T. A. Vlieger, E. Schepens, 1990 .

Opioid and D-2 receptor mediated inhibition of forskolin-stimulated cyclic AMP efflux from rat neostriatal slices

J. C. Stoof, A. Schoffelmeer, A. H. Mulder, 1987, Neuropharmacology.

Voltage-activated currents through calcium channels in rat pituitary melanotrophic cells.

J. C. Stoof, K. Kits, J. A. Keja, 1991, Neuroendocrinology.

Amantadine as N-methyl-d-aspartic acid receptor antagonist: new possibilities for therapeutic applications?

J. C. Stoof, J. Booij, B. Drukarch, 1992, Clinical Neurology and Neurosurgery.

Sustained activation does not desensitize the dopamine D2 receptor-mediated control of evoked in vitro release of radiolabeled acetylcholine from rat striatum.

J. C. Stoof, B. Drukarch, E. Schepens, 1991, European journal of pharmacology.

α 2-Adrenoceptor-mediated modulation of noradrenaline release is decreased in vas deferens but not in cerebral cortex of diabetic rats

J. C. Stoof, J. Heimans, B. Drukarch, 1989, Journal of the Neurological Sciences.

Biochemical Insights into the D-1/D-2 Receptor Interactions

J. C. Stoof, 1988 .

Restricted usefulness of tetraethylammonium and 4‐aminopyridine for the characterization of receptor‐operated K+ ‐channels

J. C. Stoof, J. Leysen, K. Kits, 1989, British journal of pharmacology.

Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease.

J. C. Stoof, E. Wolters, J. Booij, 1995, Nuclear medicine and biology.

Dopaminergic systems and parkinson's disease: Some latest developments in pathogenetic, diagnostic and pharmacotherapeutic investigations

H. Groenewegen, J. C. Stoof, P. Voorn, 1996 .

Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

J. C. Stoof, E. Wolters, J. Booij, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

3-PPP antagonizes the in vitro effects of D-1 and D-2 dopamine receptor agonists in rat neostriatum.

J. C. Stoof, A. H. Mulder, J. F. Plantjé, 1983, European journal of pharmacology.

Rigidity decreases resting tremor intensity in Parkinson's disease: A [123I]β‐CIT SPECT study in early, nonmedicated patients

J. C. Stoof, R. van Emmerik, R. Wagenaar, 2001, Movement disorders : official journal of the Movement Disorder Society.

INTERACTION OF GABA-ERGIC AND DOPAMINERGIC SYSTEMS IN THE CAUDATE NUCLEUS OF THE RAT

J. C. Stoof, A. H. Mulder, 1979 .

Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6‐hydroxydopamine‐induced lesions in the substantia nigra

J. C. Stoof, A. Cools, T. Hafmans, 2000, The European journal of neuroscience.

Dopamine D1 Receptor Agonists

J. C. Stoof, E. Wolters, B. Drukarch, 2012 .

The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐lesioned parkinsonian rhesus monkeys

J. C. Stoof, E. Wolters, B. Drukarch, 1994, Movement disorders : official journal of the Movement Disorder Society.

Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.

J. C. Stoof, M. Morelli, B. Drukarch, 1997, European journal of pharmacology.

Dihydropyridine block of omega-agatoxin IVA- and omega-conotoxin GVIA-sensitive Ca2+ channels in rat pituitary melanotropic cells.

J. C. Stoof, H. Mansvelder, K. Kits, 1996, European journal of pharmacology.

The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297.

J. C. Stoof, A. Cools, G. Andringa, 1999, Behavioural pharmacology.

Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease.

J. C. Stoof, A. Cools, G. Andringa, 1998, Advances in pharmacology.

In vitro and in vivo acetylcholine release from rat striatum as a functional paradigm of signal transduction via a D-2 dopamine receptor

J. C. Stoof, P. Boer, B. Westerink, 1992, Neurochemistry International.

Growth hormone producing cells in Lymnaea stagnalis as a model system for mammalian dopamine receptors

J. C. Stoof, T. A. Vlieger, T. Werkman, 1986 .

Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist.

J. C. Stoof, P. Voorn, B. Drukarch, 1998, Brain research. Molecular brain research.